Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2023

Open Access 01-12-2023 | Uveitis | Case report

Blau syndrome with persistent fetal vasculature: a case report

Authors: Miao Liu, Yong Zeng, Jie Zhong

Published in: Journal of Medical Case Reports | Issue 1/2023

Login to get access

Abstract

Background

Blau Syndrome (BS) is a rare autosomal dominant noncaseous granulomatous disease caused by mutations in the NOD2 gene. The disease is characterized by granulomatous dermatitis, symmetrical arthritis, and uveitis, which, if left untreated, can progress to blindness. The diagnosis of BS can be challenging because of its rarity and overlap with other rheumatologic disorders. Early detection of ocular involvement is critical to prevent vision loss and improve the prognosis of patients with BS.

Case presentation

In this report, we present a case of a five-year-old Chinese girl diagnosed with BS one year ago after presenting with a systemic rash and urinary calculi. Genetic testing was recommended by a physician, and a heterozygous mutation of the NOD2 gene c.1538T > C (p.M513T) was identified. Eight months ago, due to bilateral corneal punctate opacity, we had examined and diagnosed bilateral uveitis, bilateral corneal zonal degeneration, persistent fetal vasculature (PFV) in the right eye, and perivascular granuloma in the right eye. As a result, Vitrectomy was performed on the right eye, resulting in a significant improvement in visual acuity from 1/50 on the first day after surgery to 3/10 after 1 week. After 6 months, the visual acuity of the right eye was maintained at 3/20, but opacification of the lens posterior capsule was observed. Follow-up appointments are ongoing to monitor the condition of the affected eyes. Our report underscores the importance of prompt detection and management of ocular involvement in BS accompany with PFV to prevent vision loss and improve patient outcomes.

Conclusions

This report details the case of a child diagnosed with BS who accompanied a periretinal granuloma and PFV in the right eye. Regrettably, the left eye was observed to have no light perception (NLP) with the fundus not being visible. The occurrence of ocular complications in patients with BS, must be closely monitored to prevent vision loss and enhance treatment outcomes. This case underscores the importance of prompt diagnosis and management of ocular complications in patients with BS to prevent further damage and optimize patient outcomes.
Literature
1.
2.
go back to reference Pillai P, Sobrin L. Blau syndrome-associated uveitis and the NOD2 gene. Semin Ophthalmol. 2013;28(5–6):327–32.CrossRefPubMed Pillai P, Sobrin L. Blau syndrome-associated uveitis and the NOD2 gene. Semin Ophthalmol. 2013;28(5–6):327–32.CrossRefPubMed
3.
go back to reference Akil I, Ozguven A, Canda E, et al. Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome. Pediatr Nephrol. 2010;25(5):977–81.CrossRefPubMed Akil I, Ozguven A, Canda E, et al. Co-existence of chronic renal failure, renal clear cell carcinoma, and Blau syndrome. Pediatr Nephrol. 2010;25(5):977–81.CrossRefPubMed
4.
5.
go back to reference Emaminia A, Nabavi M, Mousavi Nasab M, Kashef S. Central nervous system involvement in Blau syndrome: a new feature of the syndrome. J Rheumatol. 2007;34(12):2504–5.PubMed Emaminia A, Nabavi M, Mousavi Nasab M, Kashef S. Central nervous system involvement in Blau syndrome: a new feature of the syndrome. J Rheumatol. 2007;34(12):2504–5.PubMed
6.
go back to reference Pac Kisaarslan A, Sözeri B, Şahin N, et al. Blau syndrome and early-onset sarcoidosis: a six case series and review of the literature. Arch Rheumatol. 2020;35(1):117–27.CrossRefPubMed Pac Kisaarslan A, Sözeri B, Şahin N, et al. Blau syndrome and early-onset sarcoidosis: a six case series and review of the literature. Arch Rheumatol. 2020;35(1):117–27.CrossRefPubMed
7.
go back to reference Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012;12(1):44–51.CrossRefPubMed Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L. Blau syndrome, clinical and genetic aspects. Autoimmun Rev. 2012;12(1):44–51.CrossRefPubMed
8.
go back to reference Rodrigues FG, Petrushkin H, Webster AR, et al. A novel pathogenic NOD2 variant in a mother and daughter with blau syndrome. Ophthalmic Genet. 2021;42(6):753–64.CrossRefPubMed Rodrigues FG, Petrushkin H, Webster AR, et al. A novel pathogenic NOD2 variant in a mother and daughter with blau syndrome. Ophthalmic Genet. 2021;42(6):753–64.CrossRefPubMed
9.
go back to reference Gass JD, Olson CL. Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol. 1976;94(6):945–50.CrossRefPubMed Gass JD, Olson CL. Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol. 1976;94(6):945–50.CrossRefPubMed
10.
go back to reference Wong M, Janowicz M, Tessler HH, Goldstein DA. High-resolution optical coherence tomography of presumed sarcoid retinal granulomas. Retina. 2009;29(10):1545–6.CrossRefPubMed Wong M, Janowicz M, Tessler HH, Goldstein DA. High-resolution optical coherence tomography of presumed sarcoid retinal granulomas. Retina. 2009;29(10):1545–6.CrossRefPubMed
11.
go back to reference Friesen ET, Phasukkijwatana N, Tsui I, Berkenstock MK, Holland GN, Sarraf D. Perivascular granulomata in the retina demonstrated by en face optical coherence tomography in a patient with Blau syndrome. Retin Cases Brief Rep. 2018;12(Suppl 1):S29–32.CrossRefPubMed Friesen ET, Phasukkijwatana N, Tsui I, Berkenstock MK, Holland GN, Sarraf D. Perivascular granulomata in the retina demonstrated by en face optical coherence tomography in a patient with Blau syndrome. Retin Cases Brief Rep. 2018;12(Suppl 1):S29–32.CrossRefPubMed
12.
go back to reference Thomas DM, Kannabiran C, Balasubramanian D. Identification of key genes and pathways in persistent hyperplastic primary vitreous of the eye using bioinformatic analysis. Front Med (Lausanne). 2021;8: 690594.CrossRefPubMed Thomas DM, Kannabiran C, Balasubramanian D. Identification of key genes and pathways in persistent hyperplastic primary vitreous of the eye using bioinformatic analysis. Front Med (Lausanne). 2021;8: 690594.CrossRefPubMed
13.
go back to reference Carreño E, Guly CM, Chilov M, et al. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). Acta Ophthalmol. 2015;93(3):253–7.CrossRefPubMed Carreño E, Guly CM, Chilov M, et al. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome). Acta Ophthalmol. 2015;93(3):253–7.CrossRefPubMed
14.
go back to reference Yasui K, Yashiro M, Tsuge M, et al. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism. Arthritis Rheum. 2010;62(1):250–7.CrossRefPubMed Yasui K, Yashiro M, Tsuge M, et al. Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism. Arthritis Rheum. 2010;62(1):250–7.CrossRefPubMed
Metadata
Title
Blau syndrome with persistent fetal vasculature: a case report
Authors
Miao Liu
Yong Zeng
Jie Zhong
Publication date
01-12-2023
Publisher
BioMed Central
Keywords
Uveitis
Arthritis
Published in
Journal of Medical Case Reports / Issue 1/2023
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-023-03983-1

Other articles of this Issue 1/2023

Journal of Medical Case Reports 1/2023 Go to the issue